Posted: February 10, 2014
Silver of Treeline Companies brokers 20,233 s/f lease at 200 Garden City Plaza; Oliver and Cimineli of NGKF represent tenant, Goldberg Segalla
According to The Treeline Cos., Goldberg Segalla, LLP, a law firm, has signed a 20,233 s/f at the company's 200 Garden City Plaza, in an expansion and relocation from 14,614 s/f at its adjacent office property, 100 Garden City Plaza.
Kraig Silver, executive vice president of Treeline, represented the owner in-house while Dan Oliver and Kyle Cimineli of Newmark Grubb Knight Frank (NGKF) negotiated on behalf of the tenant in the deal.
"The Treeline Cos. team worked closely with Goldberg Segalla on its expansion and relocation to a larger office space at 200 Garden City Plaza, a recently renovated, top-quality office building in a prime location on Long Island," said Howard Schor, COO of Treeline. "We take pride in maintaining strong relationships with our tenants, and aim to accommodate their growing needs at our office properties across Long Island and throughout the five boroughs."
Goldberg Segalla specializes in dispute resolution for a variety of disciplines including insurance coverage and reinsurance, professional liability, catastrophic personal injury, product liability, fire and arson, drug and medical device, consumer fraud and class action defense, complex commercial and business litigation, intellectual property, labor and employment, toxic tort and environmental, construction, trucking and transportation, and municipal liability.
Built in 1969 and renovated in 2001, 200 Garden City Plaza is a multi-level office building located adjacent to the Roosevelt Field Mall. The Meadowbrook Parkway, Jericho Turnpike and Old Country Rd. provide easy access to all points on Long Island and Queens.
MORE FROM Long Island
Hauppauge, NY The Suffolk County Industrial Development Agency (IDA) has granted preliminary approval of a financial incentive package that will assist a manufacturer in expanding its business by manufacturing more prescription (Rx) pharmaceuticals in addition to its existing over-the-counter